| Product NDC: | 0245-0071 |
| Proprietary Name: | Potassium Citrate |
| Non Proprietary Name: | potassium citrate |
| Active Ingredient(s): | 10 meq/1 & nbsp; potassium citrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0245-0071 |
| Labeler Name: | Upsher-Smith Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019071 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20060901 |
| Package NDC: | 0245-0071-11 |
| Package Description: | 100 TABLET in 1 BOTTLE (0245-0071-11) |
| NDC Code | 0245-0071-11 |
| Proprietary Name | Potassium Citrate |
| Package Description | 100 TABLET in 1 BOTTLE (0245-0071-11) |
| Product NDC | 0245-0071 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | potassium citrate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20060901 |
| Marketing Category Name | NDA |
| Labeler Name | Upsher-Smith Laboratories, Inc. |
| Substance Name | POTASSIUM CITRATE |
| Strength Number | 10 |
| Strength Unit | meq/1 |
| Pharmaceutical Classes | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |